Compare CGEN & DAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CGEN | DAVA |
|---|---|---|
| Founded | 1993 | 2000 |
| Country | Israel | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 191.1M | 159.1M |
| IPO Year | 2001 | 2015 |
| Metric | CGEN | DAVA |
|---|---|---|
| Price | $2.28 | $2.97 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 9 |
| Target Price | $5.00 | ★ $13.50 |
| AVG Volume (30 Days) | 242.9K | ★ 259.7K |
| Earning Date | 05-18-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $75.09 | $4.07 |
| P/E Ratio | ★ N/A | $20.02 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.30 | $2.55 |
| 52 Week High | $3.24 | $14.99 |
| Indicator | CGEN | DAVA |
|---|---|---|
| Relative Strength Index (RSI) | 47.10 | 52.47 |
| Support Level | $2.22 | $2.64 |
| Resistance Level | $2.35 | $3.03 |
| Average True Range (ATR) | 0.12 | 0.14 |
| MACD | -0.00 | 0.04 |
| Stochastic Oscillator | 30.00 | 60.58 |
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.
Endava is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2006 in the UK, and it continues to generate the majority of revenue in the UK and Europe. Endava's client base is concentrated in the payments and financial services, technology, media, and telecom industries.